Latest news with #NPI
Leader Live
23-06-2025
- Business
- Leader Live
Nice-Pak Flint took action before legislation demanded it
The Welsh Government has passed legislation banning the sale and supply of wet wipes containing plastic. From December 18, 2026, it will be illegal to sell and supply any plastic-containing consumer wet wipes in Wales. England, Scotland and Northern Ireland are expected to bring similar bans shortly. The ban covers all consumer wipes, including baby, household cleaning wipes, cosmetic and personal care wipes. Medical wipes are excluded from the ban. Read more: North Wales company continues commitment to sustainable manufacturing Nice-Pak International (NPI) with manufacturing facilities in Wales, including in Flint, and England, is Europe's largest producer of plastic-free wipes. The company supplies private label wipes for leading retailers with 96% of its UK sales being plastic-free in 2024. NPI has been a proactive partner in helping its customers transition to sustainable, plastic-free wipes and has been recognised by the Welsh Government for its active role in the consultation process. The wipes market in the UK is valued at £508 million, representing 577 million packs, with baby wipes making up the largest category at 48% of total volume. Read more: 'Raw and emotional' decision as business to close after 10-years in Mold The shift toward plastic-free wipes in retail began in 2020, led by Tesco, followed by Boots, Aldi, Asda, Morrisons, Sainsburys and Lidl. "Last year, 96% of the wipes Nice-Pak produced for the UK market were plastic-free - we took action well before legislation demanded it," said Michael Docker, managing director at Nice-Pak. "We've invested heavily in sustainable technologies across our manufacturing sites and launched a global pledge in 2020 to champion plastic-free products and recyclable packaging. Thanks to the collaboration of our suppliers and retail partners, we've helped drive large-scale, industry-wide change. Read more: Wrexham take away wins Leader Best Chippy 2025 title "We've long believed that investing in sustainable innovation is the right thing for the environment. We fully support a complete ban on plastic containing wipes and stand ready to help others make the transition. "While this ban is excellent news, it's important to clarify that plastic-free does not mean flushable. Most wipes should be disposed of in the bin. Always check the packaging for correct disposal instructions."
Business Standard
16-06-2025
- Business
- Business Standard
Zydus Life subsidiary ZHL appoints Swati Dalal as MD
Zydus Lifesciences announced that its subsidiary, Zydus Healthcare, has appointed Swati Dalal as additional director and MD for a five-year term, effective 16 June 2025. The appointment was approved by the nomination and remuneration committee (NRC). Swati Dalal is part of the senior management team at Zydus Lifesciences and brings extensive leadership experience to her new role as Managing Director of Zydus Healthcare. Swati Dalal is a seasoned commercial leader with over 30 years of rich and diverse experience in the healthcare and pharmaceutical industry. She began her career with Wockhardt Nutrition before moving to the erstwhile Boots, where she continued through successive mergers with Knoll, Solvay, and Abbott, progressively taking on leadership roles across the organisation. During her tenure at Abbott, she held various senior positions across both commercial and support functions. These included commercial director sales & marketing, as well as leadership of new product introductions (NPI), business development, and commercial excellence. She later served as managing director of Abbott Nutrition and Abbott Primary Care, and most recently, as managing director of Abbott India. Swati has also been a strong proponent of employee development and inclusion. She has led and contributed to initiatives such as women leaders of Abbott, the early career network, and has actively championed Abbotts diversity, equity, and inclusion (DEI) agenda in India. Swati holds a pharmacy degree from P.K.M. Kundnani College of Pharmacy, Mumbai and a post-graduate degree in Management Studies from Jamnalal Bajaj Institute of Management Studies in Mumbai. Swati Dalal is not related to any of the directors of Zydus Lifesciences or its wholly owned subsidiary, Zydus Healthcare. Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The companys consolidated net profit shed 0.96% to Rs 1,170.9 crore on a 17.21% rise in revenue from operations to Rs 6,290.2 crore in Q4 FY25 over Q4 FY24. Shares of Zydus Lifesciences shed 0.51% to Rs 970 on the BSE.
Business Times
15-06-2025
- Business
- Business Times
Diversified S-Reits' operating performance remains resilient amid market uncertainties
[SINGAPORE] Diversified real estate investment trusts (Reits) hold a mixture of assets across multiple sub-sectors such as industrial, retail, office and hospitality, offering investors the prospect of portfolio stability and flexibility. The larger diversified Reits in the Singapore market, or S-Reits, include Straits Times Index (STI) counters such as CapitaLand Integrated Commercial Trust (CICT), Mapletree Pan Asia Commercial Trust (MPACT) and Frasers Logistics & Commercial Trust (FLCT), as well as Suntec Reit , which is currently on the STI reserve list. Amid trade tensions and geopolitical uncertainties, business updates from these S-Reits for the first quarter ended March highlighted their ability to withstand headwinds. Most showed growth in revenue and net property income (NPI), driven by robust operating performance from existing properties and new acquisitions. Suntec Reit's revenue for Q1 2025 rose 3.4 per cent year on year (yoy) to S$113.5 million, due to stronger operating performance across all properties. Its joint venture income also grew. It reported a distribution per unit of S$0.01563 for the period, up 3.4 per cent yoy. CICT's Q1 2025 revenue was also higher, at S$395.3 million, by 1.1 per cent yoy on a like-for-like basis. Its NPI grew 1.4 per cent over the same period. For the first half of FY2025, FLCT's revenue was S$232.3 million, up 7.5 per cent yoy, while adjusted NPI rose 1.6 per cent to S$161.3 million. The growth was due mainly to full contributions from completed and acquired properties. A NEWSLETTER FOR YOU Tuesday, 12 pm Property Insights Get an exclusive analysis of real estate and property news in Singapore and beyond. Sign Up Sign Up In terms of operating performance, the larger diversified S-Reits have demonstrated resilience. For its retail portfolio, CICT reported strong momentum in rent reversion at 10.4 per cent for Q1 2025. It expects rent reversion to remain positive, although at a more moderate pace, in the next few quarters. The Reit's office portfolio also had positive rent reversion, at 5.4 per cent. Overall portfolio occupancy was stable, at 96.4 per cent as at end-March, with the occupancy standing at 98.8 per cent for retail assets and 94.7 per cent for office properties. The manager of MPACT noted that the trust's Singapore properties continued to buffer overseas headwinds. These assets contributed to higher revenue and NPI on a comparable basis in FY2025 ended March. MPACT also reported positive rent reversion from its local properties during the year, ranging from 2.2 per cent at Mapletree Business City to 16.8 per cent at VivoCity. Similarly, Suntec Reit and OUE Reit achieved positive rent reversions from their Singapore office and retail portfolios as well. Occupancy rates across their portfolios also remained stable. Suntec Reit's Singapore office portfolio had 98.7 per cent committed occupancy, down slightly from 99.4 per cent in the year-ago period. Occupancy for its local retail assets, meanwhile, improved to 98.2 per cent from 95.8 per cent over the same period. OUE Reit saw its office committed occupancy grow 1.7 percentage points quarter on quarter to 96.3 per cent as at end-March, while committed occupancy at Mandarin Gallery climbed to 99.5 per cent. These diversified S-Reits have also been reporting improvements in terms of capital management. Suntec Reit has completed a refinancing of S$730 million due in 2025 and 2026, which would result in interest savings of about S$1.8 million each year. The manager also noted it has pared down debt with proceeds from the divestment of strata office units. Meanwhile, CICT's average cost of debt as at end-March was 3.4 per cent, down 0.2 percentage point from the level in December. OUE Reit has also reported that its proactive capital management in 2024 reduced its weighted average cost of debt to 4.2 per cent a year as at end-March, from 4.7 per cent in December. The Reit managers noted that their portfolios are well-positioned to navigate economic and geopolitical uncertainties. CICT said it remains focused on asset-enhancement initiatives and portfolio-reconstitution efforts. It will continue to monitor the market for opportunities with an eye on Singapore, which offers stability, for inorganic growth. The chief executive officer of Suntec Reit's manager, Chong Kee Hiong, said continual improvement in operating performance highlights the strong fundamentals of the Reit's assets. 'In light of the global macroeconomic uncertainties, we remain focused on strengthening the operating performance of our properties,' he added. The writer is a research analyst at SGX. For more research and information on Singapore's Reit sector, visit for the S-Reits & Property Trusts Chartbook.
Yahoo
11-06-2025
- Business
- Yahoo
Mouser Electronics Brings Innovation to NEPCON Thailand 2025
SHANGHAI, June 11, 2025 /PRNewswire/ -- Mouser Electronics, Inc., the industry's leading New Product Introduction (NPI) distributor with the widest selection of semiconductors and electronic components™, is thrilled to announce that it will be participating as an exhibitor at NEPCON Thailand 2025 along with its valued partners Bel and Phoenix Contact. The exhibition will be held from June 18 - 21, 2025, at the Bangkok International Trade & Exhibition Centre (BITEC), Thailand. Visitors to Mouser booth #9F17 can explore the latest range of cutting-edge electronic and design solutions to accelerate product development. "Thailand plays a pivotal role in Mouser's growth strategy for Southeast Asia with its thriving electronics manufacturing sector and strategic position in the regional supply chain," said Daphne Tien, Vice President of Marketing and Business Development for Mouser APAC. "Our participation at NEPCON Thailand reflects our ongoing commitment to the region. We will showcase the latest innovations in semiconductor technology and electronic components, connect with industry professionals, and continue strengthening our presence in this dynamic market," she added. At the Mouser booth, attendees will have the opportunity to explore the most extensive selections of electronic components for design and prototyping. Electronics enthusiasts can access Mouser's valuable technical resources that support application development, discover tools and services designed to accelerate time to market, and engage with our Empowering Innovation Together™ series featuring game-changing podcasts on next-generation engineering challenges and trends. NEPCON Thailand 2025 is ASEAN's premier exhibition for electronics manufacturing and design. The event will bring together electronics industry professionals to explore groundbreaking ideas and products that are shaping the future of the sector. To learn more about Mouser's presence at 2025 NEPCON, please visit: For more Mouser news and our latest new product introductions, visit About Mouser Electronics Mouser Electronics is an authorized semiconductor and electronic component distributor focused on New Product Introductions from its leading manufacturer partners. Serving the global electronic design engineer and buyer community, the global distributor's website, is available in multiple languages and currencies and features more than 6.8 million products from over 1,200 manufacturer brands. Mouser offers 28 support locations worldwide to provide best-in-class customer service in local language, currency and time zone. The distributor ships to over 650,000 customers in 223 countries/territories from its 1 million-square-foot, state-of-the-art distribution facilities in the Dallas, Texas, metro area. For more information, visit View original content to download multimedia: SOURCE Mouser Electronics
Belfast Telegraph
02-06-2025
- Business
- Belfast Telegraph
Co Armagh aeroplane seat maker records operating profit over £20m
Thompson Aero Seating have made the announcement ahead of publication of their accounts for the year ending December 31 2024. The company says that the 'strong growth in financial performance' follows the 'successful completion of a three-year recovery plan'. It added 'The financial progress comes as Thompson continues to focus on operational improvement and product innovation. 'The company has introduced several changes across its operating model and supply chain to strengthen delivery performance and build greater resilience in its operations.' Thompson Aero produces luxury airline seating, and counts a number of major international airlines among its clients, including Delta, China Eastern and Singapore Airlines. Losses had accrued at the Portadown-based company in the years since the pandemic, with the company losing over £270m between 2018 and 2023. Before tax, the company lost £9.5m in 2023, which was a reduction on the £23.8m loss in 2022. Around that time, these losses were attributed in part to investment in increasing the company's 'industrial capacity' as well as 'robust industrialisation across the business.' The company's order book has been improving over recent years, with its 2023 figure of £113m increasing by £326m in 2024. Thompson Aero Seating says the large bump to the order books reflects 'growing interest in its business-class seating products within the global aerospace market'. These new products include the firm's luxury airline seats. It recently unveiled two new seats at the Aircraft Interiors Expo in Hamburg, the VantageNOVA First and the VantageXL+. The last 12 months has also seen them launch other products, including the VantageNOVA. Recent years have also seen investment in Thompson's locations and production sites, including the opening of a 'dynamic test facility' in 2023. The firm says this site enables 'in-house dynamic testing, accelerating product development and supporting the timely launch of new innovations in 2024 and 2025'. Keith Anderson, CEO, Thompson Aero Seating, said that 2024 'marked the completion of a three-year recovery plan'. 'We've delivered against our commitments, secured a strong pipeline of orders, and made tangible progress across our operations and we are now in a more stable position. 'These improvements have positioned Thompson to gain a reputation for industry-leading delivery performance and new product introduction ('NPI') execution with our customers and major aircraft manufacturers. 'It's an incredibly exciting time as the strength of our orderbook means it is imperative that we continue to develop our operating model to deliver 2x growth in the coming years. 'We are particularly proud of our industry-leading performance in NPI. Our developing operating model and our DTF have enabled this strong performance.' Thompson Aero Seating employs over 700 people, and has facilities in Banbridge and Craigavon. It has been producing flat-bed luxury seats for over 20 years. The company's seats are used on a variety of major aircraft, including the Airbus A330 and A80 and Boeing's B777 and B787.
